| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/04/2001 | US6284890 Aqueous process for the preparation of linear quinacridones having a reduced particle size |
| 09/04/2001 | US6284772 Indolo[2,1-B] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith |
| 09/04/2001 | US6284764 Antiproliferative agent |
| 09/04/2001 | US6284755 Inhibitors of prenyl-protein transferase |
| 09/04/2001 | CA2125103C 6-piperazinyl-1h-pyrazolo¬3,4-b|pyridine-3-carboxylic acids, esters, amides and related compounds, a process for their preparation and their use as medicaments |
| 08/30/2001 | WO2001062761A1 Method of preparing alkaloids using supercritical fluids from plants |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062756A1 Pyridinylimidazoles |
| 08/30/2001 | WO2001062738A1 Novel imidazoline compounds |
| 08/30/2001 | WO2001062736A1 Aryl fused azapolycyclic compounds |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062255A1 Antiviral azaindole derivatives |
| 08/30/2001 | WO2001062252A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062251A1 Tyrosine kinase inhibitors |
| 08/30/2001 | DE10009000A1 Verfahren zur Herstellung substituierter Indole A process for the preparation of substituted indoles |
| 08/30/2001 | CA2401036A1 Pyridinylimidazoles |
| 08/30/2001 | CA2400923A1 Tyrosine kinase inhibitors |
| 08/30/2001 | CA2400875A1 Tyrosine kinase inhibitors |
| 08/30/2001 | CA2400659A1 Novel imidazoline compounds |
| 08/30/2001 | CA2400435A1 Novel compounds |
| 08/30/2001 | CA2400434A1 Novel compounds |
| 08/30/2001 | CA2400293A1 Novel compounds |
| 08/29/2001 | EP1127880A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation |
| 08/29/2001 | EP1127874A2 Process for the preparation of substituted indoles |
| 08/29/2001 | EP1127059A1 Imidazonaphthyridines |
| 08/29/2001 | EP1127058A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 08/29/2001 | EP1127057A1 Naphthyridine compounds and thier azaisosteric analogues as antibacterials |
| 08/29/2001 | EP1127054A1 Novel inhibitors of impdh enzyme |
| 08/29/2001 | EP0828741B1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/29/2001 | CN1310718A Heterocyclic compound as inhibitors of rotamase enzymes |
| 08/29/2001 | CN1310714A Substituted benzoylcyclohexandiones |
| 08/29/2001 | CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/29/2001 | CN1310181A Preparation of matrine oxide |
| 08/29/2001 | CN1070192C Thiopyridine for use in control of helicobacter bacteria |
| 08/29/2001 | CN1070191C Novel quinolone-or naphthyridonecarboxylic acid derivative or salt thereof |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders |
| 08/28/2001 | US6281360 Reacting imidazopyridine compound with glyoxylic acid |
| 08/28/2001 | US6281355 Nitrogen-containing tetracyclic compounds |
| 08/28/2001 | US6281233 Method of treating gastrointestinal motility disorders |
| 08/28/2001 | US6281232 Azabicyclic ring-substituted thia- or oxadiazoles |
| 08/28/2001 | US6281228 Heterocyclic inhibitors of microsomal triglyceride transfer protein and method |
| 08/28/2001 | US6281227 Inhibitors of the activity of factor xa. |
| 08/28/2001 | US6281226 Pleuromutilin derivatives as antimicrobials |
| 08/28/2001 | US6281220 Pyrrolo(3,2-d)pyrimidin-4-amines and pyrrolo(3,2-b)pyridin-4-amines, and their use as antagonists of corticotropin-releasing factor |
| 08/28/2001 | US6281207 Treatment of movement disorders by administration of mirtazapine |
| 08/28/2001 | US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
| 08/28/2001 | CA2042113C Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
| 08/25/2001 | CA2338973A1 Keratin fibre staining compositions containing indolizine derivatives and staining process |
| 08/25/2001 | CA2338258A1 Keratin fibre staining compositions containing cationic indolizine derivatives and staining process |
| 08/23/2001 | WO2001060826A2 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 08/23/2001 | WO2001060823A1 3,9-diazabicyclo[3.3.1]nonane derivatives with analgesic activity |
| 08/23/2001 | WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001010860A3 Quinazolinone and azaquinazolinone derivatives |
| 08/23/2001 | WO2001007436A3 Substituted oxoazaheterocyclyl compounds |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | US20010015614 Novel indolizine compound, production process for novel indolizine compound, organic light-emitting device material having indolizine skeleton, and organic light-emitting device using these |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | CA2395862A1 Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production |
| 08/22/2001 | EP1125936A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases |
| 08/22/2001 | EP1125922A1 Pyrrolidine compounds and medicinal utilization thereof |
| 08/22/2001 | EP1124830A1 Pyrimidin-4-enamine as fungicide |
| 08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/22/2001 | EP1124823A1 Thrombin inhibitors |
| 08/22/2001 | EP1124822A1 Thrombin inhibitors |
| 08/22/2001 | EP1124811A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP0799210B1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
| 08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
| 08/22/2001 | CN1309325A Photographic element, compound and method |
| 08/21/2001 | US6278013 Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives |
| 08/21/2001 | US6278000 Growth-hormone secretagogues |
| 08/21/2001 | US6277993 Useful as a benzodiazepine inverse agonist, for example, as psychoanaleptic drug or drug for treatment of dysmnesia in senile dementia or alzheimer's disease |
| 08/21/2001 | US6277992 Useful as an intermediate for preparing camptothecin derivatives having antitumor activities |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
| 08/21/2001 | US6277872 Antiischemic agents; brain disorders |
| 08/21/2001 | US6277858 For protection of plants against infestation by phytopathogenic microorganisms, i.e., fungi |
| 08/21/2001 | US6277854 For treatment of tumor cells expressing an activated ras oncogene |
| 08/21/2001 | US6277851 Bicyclic amino-pyrazinone compounds |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | US6277847 Herbicidal isoindolinonyl-and 3,4-dihydroisoquinolonyl-substituted heterocycles |
| 08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
| 08/21/2001 | US6277536 Heterocyclic compounds |
| 08/21/2001 | CA2093793C Alkylidene analogs of 1'-aminospiro¬isoquinoline-4(1h),-3'-pyrrolidine|1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
| 08/21/2001 | CA2039855C Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| 08/21/2001 | CA2026143C Triazole compounds, their production and use |
| 08/16/2001 | WO2001058900A1 1h-imidazopyridine derivatives |
| 08/16/2001 | WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 08/16/2001 | WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient |
| 08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | WO2001058867A2 Novel compounds |
| 08/16/2001 | WO2001058453A1 The use of mirtazapine for the treatment of sleep disorders |
| 08/16/2001 | WO2001058427A1 Particulate composition, method for producing said composition and use of the same |
| 08/16/2001 | WO2001012180A3 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune responce |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |